The Tickborne Complete 2.0 Panel is a comprehensive blood test that evaluates exposure to Lyme disease, tickborne co-infections, and related opportunistic infections. Utilizing advanced immunofluorescence, PCR, and microarray technology, this panel provides detailed insights into tickborne pathogen activity, supporting clinical evaluation and symptom management.
You may benefit from this test if you have:
Recent tick bite or tick exposure
Unexplained fever, flu-like symptoms, or rash
Chronic muscle or joint pain
Neurological issues like dizziness or numbness
Recurring fatigue or brain fog
Cardiac symptoms linked to tickborne illness
A history of travel to Lyme-endemic areas
Suspected co-infections with Lyme disease
Comprehensive Tickborne Disease & Co-Infection Detection
- Wide Range of Pathogens detects Lyme disease, tickborne relapsing fever, and co-infections like Babesia, Bartonella, Ehrlichia, and more, providing a broader range than traditional tests.
- Multiplex PCR & Immunoassay Technology enhances detection accuracy and sensitivity, even for co-infections that often go undiagnosed with standard tests.
Holistic Health Assessment
- Comprehensive Tickborne Illness Insights supports early diagnosis of tick-related infections and autoimmune reactions, offering a complete understanding of underlying health issues.
- Guided Treatment Plans helps healthcare providers develop targeted intervention strategies for tickborne diseases and related health conditions.
Sample Report
7 Days
Sample Type
Blood
DBS
Precision Testing You Can Trust
All of our laboratory tests are performed in a CLIA-certified and CAP-accredited facility in California
The Tickborne Complete 2.0 Panel provides a full evaluation of tickborne infections
Detects immune markers associated with Lyme disease and multiple tickborne co-infections, helping assess chronic inflammation, immune dysfunction, and persistent infection symptoms. This test supports early detection and personalized treatment strategies for vector-borne illnesses.
Borrelia burgdorferi Antigens:
- VlsE1
- C6 Peptide
- p18 (DbpB)
- p23-25 (OspC)
- p28
- p30
- p31 (OspA)
- p34 (OspB)
- p39 (BmpA)
- p41
- p45
- p58
- p66
- p83-93
- Borrelia burgdorferi B31 WCS
- Borrelia burgdorferi 297 WCS
Other Borrelia Species:
- Borrelia mayonii
- Borrelia afzelii (BmpA, DbpA, OspA, OspC, p100)
- Borrelia garinii (DbpA, OspC)
- Borrelia bavariensis (DbpA, p58, VlsE1)
- Borrelia spielmanii (DbpA, OspC)
- Borrelia hermsii
- Borrelia turicatae
- Borrelia miyamotoi
- Borrelia andersonii
- Borrelia maritima
- Borrelia californiensis
- Borrelia bissettiae
- Borrelia lusitaniae
- Borrelia valaisiana
- Borrelia yangtzensis
- Borrelia turcica
- Borrelia lonestari
Why It Matters
The Tickborne Complete 2.0 tests for Lyme disease and a broad range of tickborne co-infections such as Babesia, Bartonella, and Ehrlichia. Identifying these infections early can prevent chronic symptoms like fatigue, brain fog, and joint pain, which are often misdiagnosed.
The Autoimmune Zoomer complements the Tickborne Complete 2.0 by identifying autoimmune responses that may be triggered by Lyme disease or co-infections. Chronic tickborne diseases can often lead to autoimmune reactions, exacerbating symptoms and complicating treatment.
Key Insights
Provides a comprehensive analysis of Lyme disease and its co-infections, offering critical data on the presence of tickborne pathogens that contribute to long-term health issues, especially when left untreated.
Identifies auto-antibodies and immune markers related to autoimmune conditions that may be activated by Lyme or co-infections, offering deeper insights into the immune response and providing more targeted management.
What’s Measured
Measures antibodies and immune responses to Lyme disease and co-infections, including Babesia, Bartonella, and Ehrlichia, providing a clear view of tickborne pathogens in the body.
Measures a broad range of auto-antibodies and immune markers related to autoimmune diseases, giving healthcare providers a complete picture of immune dysfunction related to tickborne diseases.
Tickborne Complete 2.0
Why It Matters
The Tickborne Complete 2.0 tests for Lyme disease and a broad range of tickborne co-infections such as Babesia, Bartonella, and Ehrlichia. Identifying these infections early can prevent chronic symptoms like fatigue, brain fog, and joint pain, which are often misdiagnosed.
Key Insights
Provides a comprehensive analysis of Lyme disease and its co-infections, offering critical data on the presence of tickborne pathogens that contribute to long-term health issues, especially when left untreated.
What’s Measured
Measures antibodies and immune responses to Lyme disease and co-infections, including Babesia, Bartonella, and Ehrlichia, providing a clear view of tickborne pathogens in the body.
Why It Matters
The Autoimmune Zoomer complements the Tickborne Complete 2.0 by identifying autoimmune responses that may be triggered by Lyme disease or co-infections. Chronic tickborne diseases can often lead to autoimmune reactions, exacerbating symptoms and complicating treatment.
Key Insights
Identifies auto-antibodies and immune markers related to autoimmune conditions that may be activated by Lyme or co-infections, offering deeper insights into the immune response and providing more targeted management.
What’s Measured
Measures a broad range of auto-antibodies and immune markers related to autoimmune diseases, giving healthcare providers a complete picture of immune dysfunction related to tickborne diseases.
1
Order Your Test
Your wellness provider orders your lab test
2
Activate Your Kit
Scan the QR CODE to activate your kit.
3
Collect Your Sample
Follow the instructions included in your test kit to collect your sample.
4
Ship Immediately
Ship your sample to our lab team for analysis.
5
Receive Personalized Results
Receive your personalized report within 2-3 weeks.
.webp?width=869&height=878&name=1%20(3).webp)
